NEW YORK, Jul 26, 2010 (BUSINESS WIRE) --
An efficient and versatile compound management operation is essential
for the success of all downstream processes in high throughput screening
(HTS) and small molecule development. The
6th Compound Management & Integrity conference taking
place September 20 -- 22, 2010 will address issues concerned with
improving both strategic and tactical aspects of compound management.
Topics to be discussed at the event include:
--
Leveraging best in class methodologies to improve quality control and
compound purity
--
Apply acoustic dispensing as a way to avoid the drawbacks of undesired
physical contact with the same sample
--
Support both HTS and multiple hit strategies with flexible processes
to increase quality, performance and capability
Participating organizations include Pfizer, Merck, AstraZeneca,
GlaxoSmithKline, Johnson &Johnson, Biogen, Sanofi-Aventis, The Scripps
Research Institute and more.
Attendees at this event will consist of compound
management, sample management, compound library, lead generation, high
throughput screening, assay development, pharmacokinetics, informatics,
drug delivery, automation and process co-ordination.
Sponsors for this event are BioFocus, Computype, Nexus, Remp, Specs
and Titian and Liconic Instruments.
For more information, visit
the website or contact Karen Richardson at karen.richardson@iqpc.com
or (646) 378 6034.
IQPC produces more than 1,500 events annually around the world, and
continues to grow. Founded in 1973, IQPC now has offices in major cities
across five continents. IQPC leverages a global research base of best
practices to produce a cross industry of information-sharing forums.
SOURCE: IQPC
IQPC
Karen Richardson, 646-378-6034
karen.richardson@iqpc.com
Copyright Business Wire 2010
|
